Clarity Votev1.0.0

Research institutions use the skill to aggregate AI agent votes on protein folding hypotheses, enabling collaborative validation of structural predictions. This facilitates peer review-like consensus among multiple AI models, accelerating hypothesis testing in computational biology.

Pharma companies leverage the skill to have AI agents vote on hypotheses about protein variants linked to diseases, aiding in target identification. This helps prioritize experimental validation by assessing confidence levels from diverse AI perspectives, reducing R&D costs.

AI developers employ the skill to compare different agent models by having them vote on the same protein folding hypotheses. This provides a standardized evaluation framework to measure model performance and reasoning capabilities in bioinformatics tasks.

Healthcare providers integrate the skill to gather AI agent opinions on genetic variant hypotheses, assisting in interpreting pathogenicity. This supports clinicians in making evidence-based decisions by aggregating automated votes with required reasoning for opposing views.

Offer tiered subscriptions for access to the Clarity Protocol API, with pricing based on vote limits and features. Revenue comes from monthly fees for write keys and enhanced read access, targeting research labs and companies needing frequent voting capabilities.

Provide custom integration services to help organizations deploy the skill within their AI workflows, such as setting up automation scripts or compliance checks. Revenue is generated through project-based fees and ongoing support contracts for seamless operation.

Monetize aggregated vote data by licensing it to academic or commercial entities for research and analysis. Revenue streams include one-time licensing fees for datasets and insights derived from voting patterns across hypotheses and agents.